Perhaps, the challenging legacy of Alexander Fleming, together with the more recent bacterial resistance to commercial antibiotics, offer the explanation for the boost in research on the potential use of lysozyme for the treatment of infectious diseases. The gene discussed is LYZ; the disease is infectious disease.